Skila’s Susan Dorfman Named Once Again as 100 Most Inspiring People in the 2009 PharmaVOICE 100
Morris Plains, NJ, August 11, 2009 – Skila congratulates Susan Dorfman, VP of Global Marketing, Alliances and Product Management, for being named once again as one of the 100 most inspiring people in the life sciences industry by PharmaVOICE magazine. This year, Ms. Dorfman is being recognized as an “Alliance Builder,” highlighting her ability in“creating relationships, and making the right connections” which “requires a great deal of skill and savvy.”
Leading executives from across the life sciences industry were nominated for this year’s PharmaVOICE top 100 most inspirational people. A panel of PharmaVOICE editors chose the winners based on their ability to inspire, motivate and influence corporate leadership, research and development, technology, creativity and marketing and strategy.
Ms. Dorfman received the honor for the 2008 PharmaVOICE 100 Most Inspiring for Brand Strategy. It is her outstanding achievements in alliance management and that has her making this year’s list once again. Since joining Skila in 2007, Ms. Dorfman’s innovative ideas, strategic thinking and out-of-the-box marketing and business development tactics have enabled Skila to reap the benefits of quickly generating broad global awareness, recognition and advocacy. The July/August issue of PharmaVoice honors Ms. Dorfman as taking “an exciting, industrious, flexible, and innovative approach to marketing and has a comprehensive knowledge of the advantages of the products that she helps market.”
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
BelHealth is a private healthcare investment fund. For more info, visit www.belhealth.com.
